The US FDA New Drug Approvals in August 2025

Shots: PharmaShots has compiled a list of US FDA-approved drugs in the month of August 2025 The US FDA has approved a total of 5 new drugs, including 5 new molecular entities, leading to the treatment of patients and advances in the pharmaceutical industry The major highlighted drug was Jazz Pharmaceuticals’ Modeyso, securing FDA approval…

ByDipanshu DixitSeptember 9, 2025

INSIGHTS+

The US FDA New Drug Approvals in July 2025

Shots: PharmaShots has compiled a list of US FDA-approved drugs in the month of July 2025 The US FDA has approved a total of 6 new drugs, including 5 new molecular entities and 1 biologic, leading to the treatment of patients and advances in the pharmaceutical industry The major highlighted drug was Regeneron’s Lynozyfic, securing…

ByDipanshu DixitAugust 12, 2025

INSIGHTS+

The US FDA New Drug Approvals in June 2025

Shots: PharmaShots has compiled a list of US FDA-approved drugs in the month of June 2025 The US FDA has approved a total of 5 new drugs, including 2 new molecular entities and 3 biologics, leading to the treatment of patients and advances in the pharmaceutical industry The major highlighted drug was Daiichi Sankyo and AstraZeneca’s Datroway, securing…

ByDipanshu DixitJuly 15, 2025

THOUGHTSPOT

10 Hidden Financial Risks Pharma Professionals Can’t Ignore

Working in the pharmaceutical industry comes with great rewards—but it’s not without its financial blind spots. High income, stock options, consulting gigs, and regulatory risk make this a unique environment where professionals can be exposed without realizing it. If you’re focused on research, development, or clinical work, it’s easy to overlook personal finance strategy. But…

ByCarla AdamsJune 30, 2025

THOUGHTSPOT

The Evolving Role of Nurses in the Pharmaceutical Industry

In today’s rapidly changing healthcare world, nurses are stepping into roles that go far beyond traditional bedside care. With the healthcare system becoming increasingly interconnected and innovation reshaping how care is delivered, new opportunities are emerging that allow nurses to use their clinical expertise in areas once reserved for scientists, researchers, and corporate professionals. One…

ByCarla AdamsJune 30, 2025

INSIGHTS+

Disease of the Month – Angina

Shots: Characterized by discomfort or pain in the chest, Angina develops when the heart does not receive adequate oxygen-rich blood PharmaShots' Disease of the Month report aims to familiarize the general population with conditions impacting communities worldwide. The report outlines disease characteristics, types, symptoms, diagnosis, treatments, epidemiology, market size, clinical trial analysis, patient advocacy groups (PAGs),…

ByDipanshu DixitJune 25, 2025

INSIGHTS+

Disease of the Month – Atherosclerosis

Shots: Characterized by the thickening or hardening of arteries due to plaque buildup, atherosclerosis leads to complications like heart attack or stroke PharmaShots' Disease of the Month report aims to familiarize the general population with conditions impacting communities worldwide. The report outlines disease characteristics, types, symptoms, diagnosis, treatments, epidemiology, market size, clinical trial analysis, patient…

ByDipanshu DixitMay 28, 2025

INSIGHTS+

Disease of the Month – Lennox-Gastaut syndrome (LGS)

Shots: Lennox-Gastaut syndrome (LGS) is a severe childhood-onset epileptic condition characterized by repeated seizures Our Disease of the Month report covers epidemiology, market size, current management strategies, emerging therapeutic options, and patient advocacy groups involved in enhancing patient care. Additionally, we are highlighting the key industry players advancing treatments for LGS For a detailed epilepsy…

ByDipanshu DixitMarch 26, 2025

THOUGHTSPOT

FDA Overview and Its Role in Transforming the Pharmaceutical Landscape

Have you ever considered whether the medicines you are taking, either over-the-counter (OTC) medicines or prescribed ones, are safe to consume and fulfill their proposed claims? Each medicine is regulated by an authorized body, the Food and Drug Administration (FDA). The FDA acts like a guardian of Public Health to mitigate the concerns about the…

ByEvans JamesAugust 30, 2024

INSIGHTS+

Disease of the Month – Gaucher Disease

Shots: Gaucher disease is a rare, autosomal recessive disorder that enlarges organs like the bone marrow, liver, and spleen by depositing fats (lipids) in them In this reprise of our Disease of the Month report, we present an enlightening description of Gaucher disease with a thorough study of epidemiology, market size, disease management, potential medicines,…

ByPrince GiriAugust 28, 2024

The US FDA New Drug Approvals in August 2025

The US FDA New Drug Approvals in July 2025

The US FDA New Drug Approvals in June 2025

10 Hidden Financial Risks Pharma Professionals Can’t Ignore

The Evolving Role of Nurses in the Pharmaceutical Industry

Disease of the Month – Angina

Disease of the Month – Atherosclerosis

Disease of the Month – Lennox-Gastaut syndrome (LGS)

FDA Overview and Its Role in Transforming the Pharmaceutical Landscape

Disease of the Month – Gaucher Disease

Contact US

OUR INFORMATION

FOLLOW US